Volume 8, Issue 11 pp. 2326-2327
CLINICAL VIDEO
Open Access

Continuous facial myokymia in multiple sclerosis

Jordan L. Clay

Corresponding Author

Jordan L. Clay

Department of Neurology, University of Virginia Health Systems, Charlottesville, VA, USA

Correspondence

Jordan L. Clay, Department of Neurology, University of Virginia Health Systems, Charlottesville, VA, USA.

Email: [email protected]

Search for more papers by this author
Mauricio F. Villamar

Mauricio F. Villamar

Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA

Kent Hospital, Warwick, RI, USA

Search for more papers by this author
First published: 16 July 2020
Citations: 2

Abstract

Facial myokymia is a clinical sign that can occur as a manifestation of demyelinating lesions. As seen in our patient with multiple sclerosis, acute-onset continuous facial myokymia can be indicative of an active lesion and can have localizing value.

A 54-year-old woman with relapsing-remitting multiple sclerosis (MS) presented with 3 days of continuous facial “quivering” after self-discontinuing dimethyl fumarate. Examination revealed continuous right perioral myokymia (Video S1). Figure 1 shows her neuroimaging. She received intravenous methylprednisolone. At 1-month follow-up, facial myokymia (FM) had resolved and dimethyl fumarate was restarted.

Details are in the caption following the image
Axial (Panel A) and sagittal (Panel B) postgadolinium T1-weighted brain MRI revealed a new enhancing lesion in the right superior pons (arrows), ipsilateral to the patient's perioral myokymia

Facial myokymia is an involuntary, abnormal activity consisting of undulating, vermicular movements.1, 2 FM has been associated with lesions of the postnuclear, postgenu portion of the ipsilateral facial nerve intra-axially in the dorsolateral pontine tegmentum.1 However, many cases show no intra-axial demyelination of the facial nerve.2 In MS patients, FM is usually self-limited.2

ACKNOWLEDGMENT

Published with written consent of the patient.

    CONFLICT OF INTEREST

    None declared.

    AUTHOR CONTRIBUTIONS

    JLC: contributed to the case concept and design, acquired the data, interpreted the data, and wrote the manuscript. MFV: contributed to the case concept and design, acquired the data, interpreted the data, and wrote the manuscript.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.